Stomach cancer physical examination

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Parminder Dhingra, M.D. [2]

Stomach cancer Microchapters


Patient Information


Historical Perspective




Differentiating Stomach Cancer from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic study of choice


History and Symptoms

Physical Examination

Laboratory Findings

Endoscopy and Biopsy

Chest X Ray



Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Stomach cancer physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Stomach cancer physical examination

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stomach cancer physical examination

CDC on Stomach cancer physical examination

Stomach cancer physical examination in the news

Blogs on Stomach cancer physical examination

Directions to Hospitals Treating Stomach cancer

Risk calculators and risk factors for Stomach cancer physical examination


Patients with stomach cancer generally appear weak. Common physical examination findings include abdominal distention, palpation of an abdominal mass, and pallor. Leser-Trelat sign and presence of Virchow's node (left supraclavicular lymphadenopathy), Sister Mary Joseph nodule (visible periumbilical nodule), Blumer's shelf (rectal mass/shelf on rectal exam) and/or Trousseau's syndrome (migratory phlebitis) on physical examination are highly suggestive of stomach cancer

Physical Examination

General Appearance







Paraneoplastic syndrome manifestations 


  1. Fuchs CS, Mayer RJ (1995). "Gastric carcinoma". N Engl J Med. 333 (1): 32–41. doi:10.1056/NEJM199507063330107. PMID 7776992.
  2. Muehldorfer SM, Stolte M, Martus P, Hahn EG, Ell C, Multicenter Study Group "Gastric Polyps" (2002). "Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study". Gut. 50 (4): 465–70. PMC 1773183. PMID 11889063.
  3. Dantzig PI (1973). "Sign of Leser-Trélat". Arch Dermatol. 108 (5): 700–1. PMID 4270762.
  4. Morgenstern L (1979). "The Virchow-Troisier node: a historical note". Am J Surg. 138 (5): 703. PMID 386813.
  5. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R (1993). "Cancer of the stomach. A patient care study by the American College of Surgeons". Ann Surg. 218 (5): 583–92. PMC 1243028. PMID 8239772.
  6. Winne BURCHARD BE (1965). "Blumer's shelf tumor with primary carcinoma of the lung. A case report". J Int Coll Surg. 44 (5): 477–81. PMID 5828299.
  7. Gilliland R, Gill PJ (1992). "Incidence and prognosis of Krukenberg tumour in Northern Ireland". Br J Surg. 79 (12): 1364–6. PMID 1336701.
  8. Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP (1979). "Microangiopathic hemolytic anemia and cancer: a review". Medicine (Baltimore). 58 (5): 377–84. PMID 481196.
  9. Wakashin M, Wakashin Y, Iesato K, Ueda S, Mori Y, Tsuchida H; et al. (1980). "Association of gastric cancer and nephrotic syndrome. An immunologic study in three patients". Gastroenterology. 78 (4): 749–56. PMID 6986318.
  10. Carmack SW, Genta RM, Graham DY, Lauwers GY (2009). "Management of gastric polyps: a pathology-based guide for gastroenterologists". Nat Rev Gastroenterol Hepatol. 6 (6): 331–41. doi:10.1038/nrgastro.2009.70. PMID 19421245.
  11. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G; et al. (2007). "Gastritis staging in clinical practice: the OLGA staging system". Gut. 56 (5): 631–6. doi:10.1136/gut.2006.106666. PMC 1942143. PMID 17142647.

Template:WH Template:WS